Home > Inhibitors & Agonists > Antibiotics and Antivirals > HBV
Cat. No. Product name CAS No.
DC10797 AB423 Featured

AB-423 is the first-generation Hepatitis B Virus Capsid Assembly inhibitor, which was generally safe and well tolerated in Phase 1 healthy volunteer studies.

1572510-80-5
DC10294 Bay 41-4109

BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.

298708-81-3
DC10085 Bay 41-4109 (racemate) Featured

BAY 41-4109 racemate is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.

298708-79-9
DC11296 GLP-26

GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.

2133017-36-2
DC10882 JNJ-632 Featured

JNJ-632 is a novel and potent inhibitor of HBV replication in vitro across genotypes A-D.

1572510-42-9
DC11260 NTCP binder peptide WD1

NTCP binder peptide WD1 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV, sodium taurocholate cotransporting polypeptide (NTCP, Kd=15 nM), reduces HBs antigen levels in culture supernatants.

DC11259 NTCP binder peptide WL4

NTCP binder peptide WL4 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV, sodium taurocholate cotransporting polypeptide (NTCP, Kd=42 nM), reduces HBs antigen levels in culture supernatants with IC50 of 0.66 uM.

DC29071 Adefovir

Adefovir (GS-0393) is an adenosine monophosphate analog antiviral agent that after intracellular conversion to Adefovir diphosphate inhibits HBV DNA polymerase. Adefovir has an IC50 of 0.7 μM against HBV in the HepG2.2.15 cell line. Adefovir has good antiviral activity against several viruses, including HBV and herpesviruses.

106941-25-7
Page 1 / Total 1 FirstPrevNextLastGoto